Kings Path Partners LLC Ligand Pharmaceuticals Inc Call Options Transaction History
Kings Path Partners LLC
- $238 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
248Shares Held
17.7MCall Options Held
61KPut Options Held
7.8K-
Black Rock Inc. New York, NY2.87MShares$355 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$238 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$125 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$119 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX707KShares$87.3 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.08B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...